Castle biosciences to participate in upcoming investor conferences

Friendswood, texas, oct. 28, 2025 (globe newswire) -- castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the stephens 27th annual investment conference on wednesday, nov. 19, 2025, at 10:00 a.m. eastern time.
CSTL Ratings Summary
CSTL Quant Ranking